🇺🇸 FDA
Patent

US 8148356

Acetylcysteine composition and uses therefor

granted A61KA61K31/195A61K31/197

Quick answer

US patent 8148356 (Acetylcysteine composition and uses therefor) held by Cumberland Pharmaceuticals Inc. expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cumberland Pharmaceuticals Inc.
Grant date
Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/195, A61K31/197, A61K31/198, A61K47/02